18181031|t|Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.
18181031|a|One of the neuropathological features of Alzheimer's disease (AD) is the deposition of senile plaques containing beta-amyloid (A beta). There is limited evidence for the treatment to arrest A beta pathology of AD. In our present study, we tested the effect of coenzyme Q10 (CoQ10), an endogenous antioxidant and a powerful free radical scavenger, on A beta in the aged transgenic mice overexpressing Alzheimer presenilin 1-L235P (leucine-to-proline mutation at codon 235, 16-17 months old). The treatment by feeding the transgenic mice with CoQ10 for 60 days (1,200 mg kg(-1) day(-1)) partially attenuated A beta overproduction and intracellular A beta deposit in the cortex of the transgenic mice compared with the age-matched untreated transgenic mice. Meanwhile, an increased oxidative stress reaction was detected as evidenced by elevated level of malondialdehyde (MDA) and decreased activity of superoxide dismutase (SOD) in the transgenic mice relative to the wild-type mice, and supplementation of CoQ10 partially decreased MDA level and upregulated the activity of SOD. The results indicate that oxidative stress is enhanced in the brain of the transgenic mice, that this enhancement may further promote A beta 42 overproduction in a vicious formation, and that CoQ10 would be beneficial for the therapy of AD.
18181031	0	12	Coenzyme Q10	Chemical	MESH:C024989
18181031	24	36	beta-amyloid	Disease	MESH:C000718787
18181031	59	74	transgenic mice	Species	10090
18181031	80	89	Alzheimer	Disease	MESH:D000544
18181031	90	102	presenilin 1	Gene	19164
18181031	154	173	Alzheimer's disease	Disease	MESH:D000544
18181031	175	177	AD	Disease	MESH:D000544
18181031	240	246	A beta	Gene	11820
18181031	303	309	A beta	Gene	11820
18181031	323	325	AD	Disease	MESH:D000544
18181031	373	385	coenzyme Q10	Chemical	MESH:C024989
18181031	387	392	CoQ10	Chemical	MESH:C024989
18181031	463	469	A beta	Gene	11820
18181031	482	497	transgenic mice	Species	10090
18181031	513	522	Alzheimer	Disease	MESH:D000544
18181031	523	535	presenilin 1	Gene	19164
18181031	536	541	L235P	ProteinMutation	tmVar:p|SUB|L|235|P;HGVS:p.L235P;VariantGroup:0;OriginalGene:19164;CorrespondingGene:5663;RS#:63749835(Expired);CorrespondingSpecies:10090;CA#:225098
18181031	543	583	leucine-to-proline mutation at codon 235	ProteinMutation	tmVar:p|SUB|L|235|P;HGVS:p.L235P;VariantGroup:0;OriginalGene:19164;CorrespondingGene:5663;RS#:63749835(Expired);CorrespondingSpecies:10090;CA#:225098
18181031	633	648	transgenic mice	Species	10090
18181031	654	659	CoQ10	Chemical	MESH:C024989
18181031	719	725	A beta	Gene	11820
18181031	759	765	A beta	Gene	11820
18181031	795	810	transgenic mice	Species	10090
18181031	851	866	transgenic mice	Species	10090
18181031	965	980	malondialdehyde	Chemical	MESH:D008315
18181031	982	985	MDA	Chemical	MESH:D008315
18181031	1047	1062	transgenic mice	Species	10090
18181031	1089	1093	mice	Species	10090
18181031	1118	1123	CoQ10	Chemical	MESH:C024989
18181031	1144	1147	MDA	Chemical	MESH:D008315
18181031	1266	1281	transgenic mice	Species	10090
18181031	1383	1388	CoQ10	Chemical	MESH:C024989
18181031	1428	1430	AD	Disease	MESH:D000544
18181031	Association	MESH:D000544	RS#:63749835(Expired);HGVS:p.L235P;CorrespondingGene:5663
18181031	Negative_Correlation	MESH:C024989	11820
18181031	Association	MESH:C000718787	19164
18181031	Negative_Correlation	MESH:C024989	MESH:C000718787
18181031	Association	MESH:D000544	19164
18181031	Negative_Correlation	MESH:C024989	MESH:D000544
18181031	Negative_Correlation	MESH:C024989	MESH:D008315
18181031	Association	MESH:D000544	11820
18181031	Association	MESH:D000544	5663

